文献速递湿疹皮炎与荨麻疹

青少年和成人特应性皮炎严重度分层:EASI、mEASI、SCORAD、oSCORAD、ADSI与BSA

Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis.
PubMed 文献 · Br J Dermatol · 2017-10-01

该研究在673例青少年和成人特应性皮炎患者中,基于研究者全球评估(IGA)的四级严重度,确认并制定了EASI、mEASI、SCORAD、oSCORAD、ADSI和BSA的严重度分层。

要点

  • oSCORAD在皮肤清除时因干燥评分可>0,SCORAD因瘙痒和失眠评分可>0。

核心结论

  • 推荐使用这些分层在临床试验中解读相应的特应性皮炎严重度评估工具。
  • 五种评估工具之间存在重要差异,深刻影响其评分的解读。

研究设计与样本

  • 研究在皮肤科诊所进行,对673例年龄≥13岁、诊断为特应性皮炎的青少年和成人进行皮肤检查。
  • 采用基于四级研究者全球评估(IGA)的锚定方法选择分层。

临床怎么用

  • 临床中可使用这些分层解读特应性皮炎严重度评估工具的评分,便于统一判断。
  • 需注意不同工具分层差异,如oSCORAD和SCORAD在皮肤清除时因干燥、瘙痒等评分可>0。

局限性

  • 研究仅纳入青少年和成人(年龄≥13岁),未涉及儿童。
  • 研究在皮肤科诊所进行,样本可能不代表一般人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Scoring systems for assessing the signs of atopic dermatitis (AD) are complex and difficult to interpret. Severity strata are helpful to interpret these assessments properly. OBJECTIVES: To confirm previously reported strata for the Eczema Area and Severity Index (EASI), Scoring Atopic Dermatitis (SCORAD) and the objective component of SCORAD (oSCORAD), and to develop strata for the modified EASI (mEASI), Atopic Dermatitis Severity Index (ADSI) and body surface area (BSA) for use in adults with AD. METHODS: Skin examination was performed in 673 adolescents and adults (age ≥ 13 years) with diagnosed AD, in a dermatology practice setting. Strata were selected using an anchoring approach based on a four-point Investigator's Global Assessment of severity (clear of active skin lesions, mild, moderate or severe disease). RESULTS: We determined potential severity strata for EASI (0 clear, 0·1-5·9 mild, 6·0-22·9 moderate, 23·0-72 severe; κ = 0·69), mEASI (0-0·9 clear, 1-8·9 mild, 9·0-29·9 moderate, 30·0-90 severe; κ = 0·71), oSCORAD (0-7·9 clear, 8·0-23·9 mild, 24·0-37·9 moderate, 38·0-83 severe; κ = 0·70), SCORAD (0-9·9 clear, 10·0-28·9 mild, 29·0-48·9 moderate, 49·0-103 severe; κ = 0·68), ADSI (0-1·9 clear, 2-5·9 mild, 6·0-8·9 moderate, 9·0-15 severe; κ = 0·55) and BSA (0 clear, 0·1-15·9 mild, 16·0-39·9 moderate, 40·0-100 severe; κ = 0·66). oSCORAD values > 0 were found in clear skin due to the presence of xerosis, which is scored in oSCORAD. Similarly, SCORAD values > 0 were found in clear skin due to the scoring of xerosis, pruritus and sleeplessness. Similarly, mEASI and ADSI scores > 0 occurred in patients with clear skin due to scoring of pruritus. CONCLUSIONS: We recommend using these strata for interpretation of their respective measures in clinical trials of AD. There are important differences between the five assessments, which profoundly impact the interpretation of their scores.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Chopra R, Vakharia PP, Sacotte R, et al. Severity strata for Eczema Area and Severity Index (EASI), modified EASI, Scoring Atopic Dermatitis (SCORAD), objective SCORAD, Atopic Dermatitis Severity Index and body surface area in adolescents and adults with atopic dermatitis. Br J Dermatol. 2017. PMID: 28485036. doi:10.1111/bjd.15641

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。